Intermediate doses of low-molecular-weight heparin for the long-term treatment of pregnancy thromboembolism. A systematic review

被引：11
|
作者：
Gandara, Esteban [1 ,2 ]
Carrier, Marc [1 ,2 ]
Rodger, Marc A. [1 ,2 ]
机构：
[1] Univ Ottawa, Dept Med, Ottawa Hosp, Thrombosis Program,Div Hematol, Ottawa, ON, Canada
[2] Ottawa Hlth Res Inst, Clin Epidemiol Unit, Ottawa, ON, Canada
来源：
THROMBOSIS AND HAEMOSTASIS | 2014年 / 111卷 / 03期
关键词：
ED AMERICAN-COLLEGE; VENOUS THROMBOEMBOLISM; ANTITHROMBOTIC THERAPY; THROMBOSIS; PREVENTION; MANAGEMENT; THROMBOPHILIA; METAANALYSIS; DALTEPARIN; VTE;
D O I：
10.1160/TH13-06-0510
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：559 / 561
页数：3
相关论文
共 50 条
  • [21] New studies of low-molecular-weight heparin in pregnancy
    Middeldorp, Saskia
    THROMBOSIS RESEARCH, 2015, 135 : S26 - S29
  • [22] Suboptimal doses of low molecular weight heparin and acute venous thromboembolism. Data from the RIETE registry
    Jesus Bruscas, Ma.
    Antonio Nieto, Jose
    Perez-Pinar, Monserrat
    Lopez-Jimenez, Luciano
    Fernandez-Capitan, Carmen
    Lopez-Chulia, Francisca
    Orue-Lecue, Ma. Teresa
    ANNALS OF HEMATOLOGY, 2007, 86 (07) : 519 - 526
  • [23] Unfractionated heparin and low-molecular-weight heparin for the initial treatment of acute venous thromboembolism
    Prandoni, P
    HAEMOSTASIS, 1998, 28 : 85 - 90
  • [24] Strategies involving low-molecular-weight heparin for the treatment and prevention of venous thromboembolism in patients with obesity: A systematic review and meta-analysis
    Liu, Junjie
    Qiao, Xi
    Wu, Mingdong
    Wang, Haiyang
    Luo, Hailong
    Zhang, Haolong
    Chen, Yikuan
    Sun, Jianming
    Tang, Bo
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [25] Intermediate Dose Low-Molecular-Weight Heparin for Thrombosis Prophylaxis: Systematic Review with Meta-Analysis and Trial Sequential Analysis
    Eck, Ruben J.
    Bult, Wouter
    Wetterslev, Jorn
    Gans, Reinold O. B.
    Meijer, Karina
    Keus, Frederik
    van der Horst, Iwan C. C.
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2019, 45 (08) : 810 - 824
  • [26] For the initial treatment of venous thromboembolism:: Are all low-molecular-weight heparin compounds the same?
    van der Heijden, JF
    Prins, MH
    Büller, HR
    THROMBOSIS RESEARCH, 2000, 100 (02) : V121 - V130
  • [27] The efficacy and safety of low-molecular-weight heparin use for cancer treatment: A meta-analysis
    Che, D. H.
    Cao, J. Y.
    Shang, L. H.
    Man, Y. C.
    Yu, Y.
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2013, 24 (05) : 433 - 439
  • [28] Low-molecular-weight heparin during pregnancy
    Bazzan, M
    Donvito, V
    THROMBOSIS RESEARCH, 2001, 101 (01) : V175 - V186
  • [29] Comparative effectiveness of low-molecular-weight heparin versus unfractionated heparin for thromboembolism prophylaxis for medical patients
    Rothberg, Michael B.
    Pekow, Penelope S.
    Lahti, Maureen
    Lindenauer, Peter K.
    JOURNAL OF HOSPITAL MEDICINE, 2012, 7 (06) : 457 - 463
  • [30] Efficacy and safety of the long-term administration of low-molecular-weight heparins in pregnancy
    Santoro, Rita
    Iannaccaro, Piergiorgio
    Prejano, Simona
    Muleto, Gaetano
    BLOOD COAGULATION & FIBRINOLYSIS, 2009, 20 (04) : 240 - 243
12345